Navigation Links
Prostate Cancer Center of New Jersey the Latest Center to Achieve High Honor of ACR-ASTRO Accreditation
Date:7/2/2012

WEST ORANGE, N.J., July 2, 2012 /PRNewswire-iReach/ -- The Prostate Cancer Center of New Jersey, a partnership between AKSM/Oncology and the Urology Group of New Jersey (UGNJ), is the latest in a rapidly growing list of prostate-only treatment centers to earn the high honor of a three-year term of accreditation in radiation oncology.

(Photo: http://photos.prnewswire.com/prnh/20120702/CG34187)

The ACR-ASTRO seal of accreditation represents the highest level of quality and patient safety, and is the result of a recent review by the American College of Radiology (ACR) and The American Society for Radiation Oncology (ASTRO). It is awarded only to facilities meeting specific Practice Guidelines and Technical Standards developed by ACR and ASTRO after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field.

"Delivering the highest quality of care has always been a priority for the urologists within the Urology Group of New Jersey," said UGNJ President Alan Krieger, MD. "This accreditation is reflective of our commitment to quality and excellence, not only to our patients, but to the greater community as well."

During the Prostate Cancer Center of New Jersey's review and on-site survey, patient care and treatment, patient safety, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs were assessed. The Prostate Cancer Center of New Jersey received an unqualified recommendation which means there were no deficiencies that needed improvement. "Dr. Robert Ivker, the Center's Board-Certified Radiation Oncologist, and his staff are major reasons our ACR review was so flawless. His efforts and skills as a physician are greatly appreciated," said Krieger.

AKSM/Oncology both manages and staffs the Prostate Cancer Center of New Jersey and is the market leader providing radiation therapy services in conjunction with urologists throughout the United States. AKSM/Oncology spent years planning and creating prostate-only treatment centers in partnership with urologists and radiation oncologists to assure the highest clinical standards and protocols were adopted and implemented.

"Clinical quality and the highest level of patient care is the cornerstone by which these prostate-only cancer treatment centers have been created. Clinical quality is an ongoing process that requires diligence and commitment of all the parties. On behalf of men throughout the United States we applaud ASTRO for continuing to recognize these centers for their excellence," said AKSM/Oncology National Clinical Director Donald Jackson.

Jackson also stated that prostate cancer patients overwhelmingly support treatment at urology-integrated centers like the Prostate Cancer Center of New Jersey (click to see videos), and that additional AKSM/Oncology-operated centers are currently seeking ACR accreditation.

The ACR is a national professional organization serving more than 34,000 diagnostic/interventional radiologists, radiation oncologists, nuclear medicine physicians, and medical physicists with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive health care services. ASTRO is a professional organization serving more than 10,000 radiation oncologists, medical physicists and other health care professionals involved in the treatment of cancer patients.

AKSM/Oncology is a urologist-owned and operated company that has earned a national reputation for its radiation center expertise. AKSM/Oncology, Inc. is a subsidiary of AKSM, Ltd. a national provider of technology and services by urologists for urologists since 1986.

The achievement by the Prostate Cancer Center of New Jersey is just the latest in concerted efforts by the Urology Group of New Jersey to assure the highest levels of patient safety and quality care. Earlier this month UGNJ earned The Joint Commission's Gold Seal of Approval™ for accreditation by demonstrating compliance with The Joint Commission's national standards for health care quality and safety in ambulatory care organizations. The accreditation award recognizes UGNJ's dedication to continuous compliance with The Joint Commission's state-of-the-art standards. Urology Group of New Jersey's 28 urologists offer patients a comprehensive range of services providing the very best in urological care through the latest technology and state-of-the-art equipment. UGNJ has locations in Essex, Hudson, Morris and Union counties.

Media Contact: Gary Stelluti Health Care Marketing Strategies, LLC, 614-775-9659, gary@hcmarketing.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Prostate Cancer Center
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
2. Prostate Cancer and Bone Health
3. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
4. Breakthrough Prostate Cancer Diagnostics
5. Arkansas Prostate Cancer Center Earns High Honor of ACR-ASTRO Accreditation
6. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
7. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
8. US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
9. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... England och PITTSBURGH ... Erbjudandet lämnas inte, och detta pressmeddelande ... indirekt, i eller till, och inga anmälningssedlar ... av aktieägare i, något land där Erbjudandet, ... accept av Erbjudandet skulle strida mot tillämpliga ...
(Date:2/10/2016)... February 10, 2016 A new report from business intelligence ... states that the Alzheimer,s disease market will more than double from just under ... Compound Annual Growth Rate (CAGR) of 11%. Canada , ... , Spain , the UK, and Japan ... forecast period. --> Canada , France ...
(Date:2/10/2016)... , Feb. 10, 2016 Urologix, the ... the treatment of Benign Prostatic Hyperplasia (BPH), announces new ... Ash Keswani , a medical device industry veteran of ... the Limited Liability Company.  Plymouth, ... service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, will ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th annual meeting ... Congress (WMIC), will be held in New York City, NY on September 7 ... The congress will highlight and emphasize how imaging reveals a greater understanding of ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... working together to expand dental health services to the developmentally disabled in the ... Care Dental’s operations to a new facility at 71-949 Highway 111, Suite 100-B, ...
(Date:2/10/2016)... ... 10, 2016 , ... Compliancy Group LLC is pleased to ... throughout the country. The Guard was specifically designed to handle each element required ... regulatory updates, and compliance coaching. , In addition to meeting the compliance needs ...
(Date:2/10/2016)... ... ... Dr. Jessica Barron, of Barron Family Dental in Thornton, Colorado , ... in the North Metro Denver area. The new dental practice focuses on comfort where ... in the most relaxing environment. , While some dental visits can create anxiety for ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology ... quarter and full year ended December 31, 2015 on Monday, February 29, 2016 after ... the investment community following the release at 4:30 PM ET. Investors interested in participating ...
Breaking Medicine News(10 mins):